Plasmapheresis physically washes harmful antibodies out of the blood. It works best when a disease is caused by one clear circulating antibody rather than by tissue inflammation alone.
- Wegener's granulomatosis: A small vessel vasculitis driven by ANCA antibodies plus granulomatous inflammation. Steroids and cyclophosphamide or rituximab are the main treatment; plasmapheresis is kept in reserve for severe lung bleeding or kidney failure, not the standard answer.
- HSP: An IgA linked vasculitis in children, usually mild and self limiting. It settles with rest, fluids, and sometimes steroids. Plasma exchange is not part of routine care.
- Goodpasture syndrome: Caused entirely by anti-GBM antibodies attacking the kidney and lung basement membrane. Since the antibody itself is the disease, taking it out of the blood with plasmapheresis, alongside steroids and immunosuppressants, is a core, well established treatment.
- Guillain-Barre syndrome: Also responds to plasma exchange, which removes antibodies against peripheral nerve myelin, but it is not the option that most directly matches "one antibody causes the whole disease" the way Goodpasture syndrome does.
The strongest, most classic match for plasmapheresis among these four is Goodpasture syndrome, because the anti-GBM antibody is both the cause and the direct target of the therapy.
Let's summarize:
- Plasmapheresis suits diseases where one circulating antibody drives the damage.
- Goodpasture syndrome is the textbook example, anti-GBM antibody attacking kidney and lung.
- Wegener's and Guillain-Barre syndrome can use plasma exchange in severe cases, but they are not the primary teaching example here.
So the condition where plasmapheresis is classically useful is Goodpasture syndrome.